Sight Sciences, Inc. is projected to rise to $7.59 by 2027, a +44% move from its current price of $5.26. SGHT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.12 | $5.26 | $5.41 | +0.04% |
| Aug 4 | $5.06 | $5.26 | $5.47 | +0.08% |
| Aug 5 | $5.02 | $5.27 | $5.52 | +0.12% |
| Aug 6 | $4.99 | $5.27 | $5.57 | +0.16% |
| Aug 7 | $4.96 | $5.27 | $5.60 | +0.21% |
| Aug 8 | $4.93 | $5.27 | $5.64 | +0.25% |
| Aug 9 | $4.91 | $5.28 | $5.67 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.91 | $5.28 | $5.67 | +0.29% |
| Week 2 | $4.77 | $5.29 | $5.86 | +0.58% |
| Week 3 | $4.68 | $5.31 | $6.02 | +0.87% |
| Week 4 | $4.60 | $5.32 | $6.15 | +1.16% |
| Week 5 | $4.54 | $5.34 | $6.28 | +1.45% |
| Week 6 | $4.48 | $5.35 | $6.39 | +1.74% |
| Week 7 | $4.43 | $5.37 | $6.50 | +2.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sight Sciences, Inc. is an ophthalmic medical device company focused on developing and commercializing surgical and nonsurgical technologies for treating eye diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye, and offers the OMNI family of products, including OMNI Ergo and OMNI EDGE.
It also provides SION, a bladeless and manually operated device for ophthalmic procedures, and TearCare, a system designed to address meibomian gland disease in evaporative dry eye. The company serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. Sight Sciences was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences trades at $5.12 per share and has a market capitalization of $278.58M. Its rank is 3395 in the market. The current price and market position sit within a forecast that projects multi-year upside, with the average price evolving from $5.12 in 2026 toward higher levels in 2030 and beyond.
A major floor 34.4% below — a decisive break under it would weaken the trend.
The nearest floor, 10.6% below — buyers have tended to step in here.
The nearest ceiling, 11.0% above — a clean break opens room to run.
A major ceiling 21.8% above — clearing it would confirm fresh momentum.
Key SGHT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SGHT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.26 | Buy | $5.22 | Buy |
| MA 10 | $5.09 | Buy | $5.18 | Buy |
| MA 20 | $5.18 | Buy | $5.17 | Buy |
| MA 50 | $5.09 | Buy | $5.07 | Buy |
| MA 100 | $4.60 | Buy | $5.02 | Buy |
| MA 200 | $5.54 | Sell | $5.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.23 | Neutral |
| Stoch RSI (14) | 86.73 | Sell |
| CCI (20) | 35.20 | Neutral |
| Williams %R (14) | -12.50 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 0.19 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 87.50 | Sell |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 55.73 | Neutral |
| Momentum (10) | 0.23 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 5.40 | Sell |
| ADX (14) | 11.29 | Neutral |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The stock trades near the SMA50 of $5.06 and below the SMA200 of $5.49, indicating a mixed short-term trend. Key supports and resistances are $4.70 and $5.84, respectively.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.45 | $5.26 | $7.42 | 0% | Neutral | |
| $6.05 | $7.59 | $10.06 | +44% | Bullish | |
| $6.18 | $7.98 | $10.99 | +52% | Bullish | |
| $6.83 | $9.02 | $12.80 | +72% | Bullish | |
| $7.22 | $9.73 | $14.15 | +85% | Bullish | |
| $7.59 | $10.43 | $15.50 | +98% | Bullish | |
| $9.71 | $13.58 | $20.57 | +158% | Bullish | |
| $10.78 | $15.32 | $23.61 | +191% | Bullish | |
| $11.57 | $16.70 | $26.16 | +218% | Bullish | |
| $12.87 | $18.87 | $29.99 | +259% | Bullish | |
| $18.92 | $29.68 | $50.20 | +464% | Bullish | |
| $32.22 | $56.79 | $105.15 | +980% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.45 | $5.26 | $6.54 | +0.00% |
| September 2026 | $4.67 | $5.52 | $6.72 | +5.01% |
| October 2026 | $4.58 | $5.46 | $6.72 | -1.14% |
| November 2026 | $4.70 | $5.63 | $6.99 | +3.12% |
| December 2026 | $4.93 | $5.94 | $7.42 | +5.42% |
Click any year to see its month-by-month SGHT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SGHT is projected to trade between $3.45 and $7.42, averaging $5.26 — a potential gain of 0% from today's $5.26. A consolidation phase looks the most probable path here.
Sight Sciences, Inc.'s 2027 outlook centres on $7.59, within a $6.05 to $10.06 range. That is up +44% on the projected 2026 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2028, SGHT could reach as high as $10.99, with a base case around $7.98 and support toward $6.18 — roughly +52% from $5.26. Buyers look set to stay in control over this stretch.
Expect SGHT to range from $6.83 to $12.80 through 2029. The $9.02 average target implies a +72% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The SGHT price prediction for 2030 points to an average of $9.73 (low $7.22, high $14.15) — a potential gain of +85% on today's $5.26. Buyers look set to stay in control over this stretch.
In 2031, SGHT is projected to trade between $7.59 and $15.50, averaging $10.43 — a potential gain of +98% from today's $5.26. That is up +7% on the projected 2030 average. Momentum favours further upside here.
Sight Sciences, Inc.'s 2032 outlook centres on $13.58, within a $9.71 to $20.57 range. That is up +30% on the projected 2031 average. That marks a +158% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, SGHT could reach as high as $23.61, with a base case around $15.32 and support toward $10.78 — roughly +191% from $5.26. Momentum favours further upside here.
Expect SGHT to range from $11.57 to $26.16 through 2034. The $16.70 average target implies a +218% move from current prices. That is up +9% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The SGHT price prediction for 2035 points to an average of $18.87 (low $12.87, high $29.99) — a potential gain of +259% on today's $5.26. Momentum favours further upside here.
In 2040, SGHT is projected to trade between $18.92 and $50.20, averaging $29.68 — a potential gain of +464% from today's $5.26. That is up +57% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Sight Sciences, Inc.'s 2050 outlook centres on $56.79, within a $32.22 to $105.15 range. That is up +91% on the projected 2040 average. That marks a +980% change versus current levels. Momentum favours further upside here.
Investing $1,000 in SGHT today (≈ 190.114068 SGHT) could be worth
$10,795.97
+$9,795.97 (+980%) by 2050 · US Dollar
Based on the average projected SGHT price of $56.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SGHTwould be worth at today's price.
$1,000 invested in SGHT on Jul 31, 2025 (≈ 300.300307 SGHT) would be worth
$1,579.58
+$579.58 (+58.0%) today · 1.58× · US Dollar
Based on a SGHT entry price of $3.33 vs. today's $5.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.91 | $1,071.28 | +7.1% |
| 1 month ago | $5.44 | $966.91 | -3.3% |
| 3 months ago | $4.45 | $1,182.02 | +18.2% |
| 6 months ago | $6.44 | $816.77 | -18.3% |
| 1 year ago | $3.33 | $1,579.58 | +58.0% |
| All time (5.0y) ago | $39 | $134.87 | -86.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SGHT forecast.
Our base-case forecast reaches $11.00 around 2032.
Implied market cap at $11.00: $598.51M
The multi-year forecast shows a bullish trajectory from 2027 onward. The 2026 forecast shows an average of $5.12 with 0% ROI and NEUTRAL sentiment. By 2027, the average rises to $7.48 with a 46.1% ROI and bullish sentiment, continuing through 2028 (avg $7.72, 50.9% ROI) and 2029 (avg $8.58, 67.6% ROI).
2030 projects an average of $9.05 with a 76.7% ROI, and 2031–2035 show continued gains (2031 avg $9.54, 86.3% ROI; 2032 avg $12.58, 145.7% ROI; 2033 avg $14.18, 176.9% ROI; 2034 avg $15.48, 202.4% ROI; 2035 avg $17.36, 239.1% ROI). The long-range outlook extends to 2040 (avg $26.87, 424.8% ROI) and 2050 (avg $49.21, 861% ROI), with sentiment remaining BULLISH. These figures are forecasts and not guarantees; actual results depend on various factors impacting the business and markets.
Tap a question to reveal the answer.
Average price $9.05; minimum $6.46; maximum $13.71; ROI 76.7%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with rising averages and ROIs (e.g., 2027 avg $7.48, ROI 46.1%; 2030 avg $9.05, ROI 76.7%; 2050 avg $49.21, ROI 861%). These are estimates and not guarantees.
Yes. The 2034 max is $25.57 and the 2035 max is $29.16, indicating that upside above $25 appears in the forecast.
Current price is $5.12 and market capitalization is $278.58M. The rank is 3395.
RSI14 is 50 (NEUTRAL). The SMA50 is $5.06 and the SMA200 is $5.49. Support is at $4.70 and resistance at $5.84, with a 30-day range from $4.11 to $6.37 and annualized volatility of 60%.
Sight Sciences, Inc. Community Discussion
0Share your Sight Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.